prikaz prve stranice dokumenta Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
  Download
PDF 1.49 MB
Scientific paper - Review paper
Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
Canadian Journal of Gastroenterology and Hepatology, 2020 (2020); 1-12. https://doi.org/10.1155/2020/8859719
Mikolašević, Ivana; Pavić, Tajana; Filipec Kanižaj, Tajana; Vranešić Bender, Darija; Domislović, Viktor; Krznarić, Željko

Cite this document

Mikolašević, I., Pavić, T., Filipec Kanižaj, T., Vranešić Bender, D., Domislović, V. & Krznarić, Ž. (2020). Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?. Canadian Journal of Gastroenterology and Hepatology, 2020., 1-12. doi: 10.1155/2020/8859719

Mikolašević, Ivana, et al. "Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?." Canadian Journal of Gastroenterology and Hepatology, vol. 2020, 2020, pp. 1-12. https://doi.org/10.1155/2020/8859719

Mikolašević, Ivana, Tajana Pavić, Tajana Filipec Kanižaj, Darija Vranešić Bender, Viktor Domislović and Željko Krznarić. "Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?." Canadian Journal of Gastroenterology and Hepatology 2020 (2020): 1-12. https://doi.org/10.1155/2020/8859719

Mikolašević, I., et al. (2020) 'Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?', Canadian Journal of Gastroenterology and Hepatology, 2020, pp. 1-12. doi: 10.1155/2020/8859719

Mikolašević I, Pavić T, Filipec Kanižaj T, Vranešić Bender D, Domislović V, Krznarić Ž. Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?. Canadian Journal of Gastroenterology and Hepatology [Internet]. 2020 October 31 [cited 2024 November 19];2020:1-12. doi: 10.1155/2020/8859719

I. Mikolašević, T. Pavić, T. Filipec Kanižaj, D. Vranešić Bender, V. Domislović and Ž. Krznarić, "Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?", Canadian Journal of Gastroenterology and Hepatology, vol. 2020, pp. 1-12, October 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:506848. [Accessed: 19 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
AuthorIvana Mikolašević
AuthorTajana Pavić
AuthorTajana Filipec Kanižaj
AuthorDarija Vranešić Bender
AuthorViktor Domislović
AuthorŽeljko Krznarić
Author's institution(Sestre milosrdnice University Hospital Center)
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it is evident that they share several common features. Crucial mechanisms involved in sarcopenia-nonalcoholic fatty liver disease (NAFLD) interplay are based on effects of insulin resistance, chronic inflammation, oxidative stress, and crosstalk between organs by secretion of cytokines (hepatokines, adipokines, and myokines). Currently, published studies confirm the association of sarcopenia with the degree of NAFLD defined by liver histology. However, prospective studies that will give us information regarding the causal effect of NAFLD and sarcopenia are still needed. Furthermore, there is a need for a patient-friendly, noninvasive, low-cost method for detection of loss of skeletal muscle mass, strength, and physical performance in the context of NAFLD. Moreover, potential treatment strategies such as physical exercise and nutritional supplementation, that are usually a part of management of sarcopenia, should also be investigated in NAFLD patients, especially given the fact that for now, we do not have a good treatment option for NAFLD. Therefore, future investigations should combine studies on NAFLD and sarcopenia in terms of physical activity and nutritional interventions such as vitamin D supplementation. This review aims to report recent evidence concerning the links between sarcopenia and NAFLD and methods to assess sarcopenia.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleCanadian Journal of Gastroenterology and Hepatology
Numberingvol. 2020, pp. 1-12, 8859719
p-ISSN2291-2789
e-ISSN2291-2797
DOIhttps://doi.org/10.1155/2020/8859719
URN:NBNurn:nbn:hr:184:506848
Publication2020-10-31
Document URLhttps://www.hindawi.com/journals/cjgh/2020/8859719/
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2021-01-19 21:06:57